Europe Cancer Screening Market 2018-2023 with F. Hoffman La Roche, Bayer, Johnson & Johnson, Pfizer, and Merck & Co. Dominating - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 20, 2018--The “Europe Cancer Screening Market (2018-2023)” report has been added to ResearchAndMarkets.com’s offering.
Europe after North America is the second largest market leading the cancer screening market. The market is forecasted to grow at a compound annual growth rate of (CAGR) of 8.1% resulting in an annual revenue of USD 22.43 billion during the forecast period (2018-2023).
Increase in the aging population along with the rise in the number of cancer incidences is a key driving factor for the market. Western Europe is moving fast towards the adoption of performance-based remuneration systems.
By end users, the market is segmented into hospitals, laboratories and independent physicians and clinics. The Laboratory segment will witness a progressive growth during the forecast period 2018-2023 while the hospital segment will account for the maximum revenue of USD 11.18 billion during the forecast period.
By screening type, the market is segmented into laboratory, genetic, imaging, biopsy and endoscopy tests. Genetic, biopsy and endoscopy will be the leading segments during the forecast period 2018-2023.
By application type, the market can be segmented into lung, breast, melanoma, kidney and colorectal cancer types. Colorectal, kidney, melanoma and breast cancer will occupy a larger share of the market during the forecast period 2018-2023.
By countries, the market is divided into the United Kingdom (U.K.), France and Germany.
Key Growth FactorsRise in the aging population, changing environmental conditions along with the adoption of a sedentary lifestyle is contributing to more cancer-related cases.
ThreatsStringent regulations along with regulatory inter and intra state barriers pose many challenges for the region. Lack of associated funding and transparency in medical procedures turn out to be as threats to the market. Key Players ProfiledF. Hoffman La Roche Ltd.Bayer AGJohnson & JohnsonPfizerMerck & Co.
Chapter 1. Executive Summary
Chapter 2. Europe Cancer Screening Market - Market Overview
Chapter 3. The UK Cancer Screening Market
Chapter 4. Germany Cancer Screening Market
Chapter 5. Others (The Rest of Europe) Cancer Screening Market
Chapter 6. Competitive Landscape
Chapter 7. Conclusion
For more information about this report visit https://www.researchandmarkets.com/research/s4vqfb/europe_cancer?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181120005316/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES ONCOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 11/20/2018 06:39 AM/DISC: 11/20/2018 06:39 AM